Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.
Featured Items
New Content
The event, held Tuesday, June 11, focused on sharing two decades of experience caring for 9/11 responders living with the enduring effects of exposure to psychological trauma and environmental toxins.
Mount Sinai Rehabilitation Physicians Featured in new Documentary film “Quad Gods”
See the official trailer for the Quad Gods documentary on HBO
A recent study conducted at Mount Sinai Hospital has demonstrated the safety and effectiveness of the Menon Precision Prostatectomy (MPP), a surgical technique for treating prostate cancer while preserving urinary and sexual functions.
Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.
Join Mount Sinai for the Eighth Annual Endoscopic Middle Ear Surgery Dissection CME Course
Friday, September 13, 7:30am- Saturday, September 14, 2:00pm
Researchers from the Icahn School of Medicine at Mount Sinai have shed valuable light on the nuanced functions and intricate regulatory methods of RNA editing, a critical mechanism underlying brain development and disease.
Mount Sinai Fuster Heart Hospital: 2023 Clinical Outcomes and Innovations Report
The Cardiac Catheterization Laboratory at The Mount Sinai Hospital is among the highest volume centers, yet also among the safest interventional catheterization laboratories in the United States.
Dr. Michael Rothschild shares dysphagia in children, standards for evaluation and management of some common causes
Dr. Rebecca Trachtman discusses the most common pediatric rheumatic digestive diseases affecting the esophagus and airway
New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes
Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease (CAD), the leading ...
The European Society for Clinical Investigation (ESCI) is awarding Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, its ESCI Distinguished Medal for 2024. He received this honor ...
This recent study uncovers a potential new therapy, improved an existing treatment, and identified a disease biomarker in mice with PDHD
"The Genesis of Schizophrenia: An Origin Story” by Mount Sinai researcher Rebecca Birnbaum, MD, and Daniel Weinberger, MD, Director and CEO of the Lieber Institute for Brain Development (LIBD) on the Johns Hopkins medical campus, is featured ...
Researchers Identify a Genetic Cause of Intellectual Disability Affecting Tens of Thousands
Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease (CAD), the leading ...
A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol ...
Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, was awarded the WHF Lifetime Achievement Award 2024 from the World Heart Federation to publicly recognize his remarkable contributions to the mission of the ...
Working under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular ...
One of the biggest challenges in managing aggressive and locally advanced prostate cancer is how best to balance the competing goals of achieving cancer control with maintaining continence and sexual function among patients.